Eleanor Berrie
- Co-authors
- G HalePaul G. SchlegelH. Bobby GasparMalcolm K. BrennerKanchan RaoPersis AmroliaPaul LandaisNicholas Goulden
- Topics
- Monoclonal and Polyclonal Antibodies Research (2 papers)Neuroblastoma Research and Treatments (1 paper)SARS-CoV-2 and COVID-19 Research (1 paper)
- Cited by
- HematologyImmunologyOncology
- Journals
- The LancetBloodThe Lancet Microbe
- Partner nations
- United KingdomGermanyFrance
In The Last Decade
Eleanor Berrie
4 papers receiving 105 citations
Peers
Comparison fields: 5 of 31
- Immunology 59
- Hematology 54
- Oncology 33
- Genetics 23
- Radiology, Nuclear Medicine and Imaging 21
Countries citing papers authored by Eleanor Berrie
This map shows the geographic impact of Eleanor Berrie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleanor Berrie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleanor Berrie more than expected).
Fields of papers citing papers by Eleanor Berrie
This network shows the impact of papers produced by Eleanor Berrie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleanor Berrie. The network helps show where Eleanor Berrie may publish in the future.
Co-authorship network of co-authors of Eleanor Berrie
This figure shows the co-authorship network connecting the top 25 collaborators of Eleanor Berrie. A scholar is included among the top collaborators of Eleanor Berrie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleanor Berrie. Eleanor Berrie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 76 | |
| 3 | Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemia. | 27 |
| 4 | 4 |
About Eleanor Berrie
Eleanor Berrie is a scholar working on Modeling and Simulation, Genetics and Hematology, having authored 4 papers that have together received 108 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (2 papers), Neuroblastoma Research and Treatments (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Hematology (54 citations), Immunology (59 citations) and Oncology (33 citations). Eleanor Berrie has collaborated with scholars based in United Kingdom, Germany and France. Frequent co-authors include G Hale, Paul G. Schlegel, H. Bobby Gaspar, Malcolm K. Brenner, Kanchan Rao, Persis Amrolia, Paul Landais, Nicholas Goulden, Stuart Adams and Andrew R. Gennery. Their work appears in journals such as The Lancet, Blood and The Lancet Microbe.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.